تجاوز إلى المحتوى الرئيسي
drug protocol number
TMC435HPC3014
drug sponsor
Janssen-Cilag International NV
drug study
TMC435 (simeprevir)
drug trial site
KFSH & RC-R
drug status
Completed
drug phase